These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 24981297)

  • 1. HPV vaccination in head and neck HPV-related pathologies.
    Wierzbicka M; Józefiak A; Jackowska J; Szydłowski J; Goździcka-Józefiak A
    Otolaryngol Pol; 2014; 68(4):157-73. PubMed ID: 24981297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
    Osazuwa-Peters N
    Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of HPV in head and neck cancer and review of the HPV vaccine.
    D'Souza G; Dempsey A
    Prev Med; 2011 Oct; 53 Suppl 1(Suppl 1):S5-S11. PubMed ID: 21962471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study.
    Haeussler K; Marcellusi A; Mennini FS; Favato G; Picardo M; Garganese G; Bononi M; Costa S; Scambia G; Zweifel P; Capone A; Baio G
    Value Health; 2015 Dec; 18(8):956-68. PubMed ID: 26686779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic human papilloma virus vaccination in head and neck: indications and future perspectives.
    Wierzbicka M; Berkhof JH; Dikkers FG
    Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):85-90. PubMed ID: 30694913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Expanded Impact of Human Papillomavirus Vaccine.
    Pahud BA; Ault KA
    Infect Dis Clin North Am; 2015 Dec; 29(4):715-24. PubMed ID: 26610422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The first vaccine against cancer: the human papillomavirus vaccine].
    Bősze P
    Orv Hetil; 2013 Apr; 154(16):603-18. PubMed ID: 23587540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?
    Takes RP; Wierzbicka M; D'Souza G; Jackowska J; Silver CE; Rodrigo JP; Dikkers FG; Olsen KD; Rinaldo A; Brakenhoff RH; Ferlito A
    Oral Oncol; 2015 Dec; 51(12):1057-60. PubMed ID: 26520047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-generation prophylactic HPV vaccines: current options and future strategies for vaccines development.
    Fruscalzo A; Londero AP; Bertozzi S; Lellè RJ
    Minerva Med; 2016 Feb; 107(1):26-38. PubMed ID: 26473283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
    Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
    Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus vaccine introduction--the first five years.
    Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM
    Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease.
    Dasbach EJ; Elbasha EH; Insinga RP
    Epidemiol Rev; 2006; 28():88-100. PubMed ID: 16740585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
    Vetter KM; Geller SE
    J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Committee Opinion Summary No. 641: Human Papillomavirus Vaccination.
    Obstet Gynecol; 2015 Sep; 126(3):693. PubMed ID: 26287785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.
    Gillison ML; Alemany L; Snijders PJ; Chaturvedi A; Steinberg BM; Schwartz S; Castellsagué X
    Vaccine; 2012 Nov; 30 Suppl 5():F34-54. PubMed ID: 23199965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of current practices, attitudes, and knowledge regarding human papillomavirus-related cancers and vaccines among head and neck surgeons.
    Malloy KM; Ellender SM; Goldenberg D; Dolan RW
    JAMA Otolaryngol Head Neck Surg; 2013 Oct; 139(10):1037-42. PubMed ID: 23989246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.
    Chatterjee A
    Expert Rev Vaccines; 2014 Nov; 13(11):1279-90. PubMed ID: 25256262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Knowledge of the Role of Papillomavirus-Related Head and Neck Pathologies among General Practitioners, Otolaryngologists and Trainees. A Survey-Based Study.
    Jackowska J; Bartochowska A; Karlik M; Wichtowski M; Tokarski M; Wierzbicka M
    PLoS One; 2015; 10(10):e0141003. PubMed ID: 26501885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.